Dexrazoxane Intravenous and Sodium Phenylbutyrate Tablets
Determining the interaction of Dexrazoxane Intravenous and Sodium Phenylbutyrate Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dexrazoxane
Brand name: Totect, Zinecard
Synonyms: Dexrazoxane
Generic Name: sodium phenylbutyrate
Brand name: Buphenyl
Synonyms: Sodium phenylbutyrate, Sodium Phenylbutyrate Powder
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dexrazoxane Intravenous-Sodium phosphate dibasic and sodium phosphate monobasic
- Dexrazoxane Intravenous-Sodium phosphate dibasic and sodium phosphate monobasic Rectal
- Dexrazoxane Intravenous-Sodium phosphate p 32 Intravenous
- Dexrazoxane Intravenous-Sodium Phosphates
- Dexrazoxane Intravenous-Sodium Phosphates Enema
- Dexrazoxane Intravenous-Sodium Phosphates Injection
- Sodium Phenylbutyrate Tablets-Dextenza Insert
- Sodium Phenylbutyrate Tablets-Dextenza intraocular
- Sodium Phenylbutyrate Tablets-Dextran 40
- Sodium Phenylbutyrate Tablets-Dextran 70 6% in 5% Dextrose high molecular weight
- Sodium Phenylbutyrate Tablets-Dextran 75
- Sodium Phenylbutyrate Tablets-Dextran high molecular weight